(Q48284780)

10 February 2018

title

Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type. (English)

1 reference

10 February 2018

0 references

1 reference

1 reference

1

Quirion R

1 reference

10 February 2018

author name string

Martel JC

2

1 reference

10 February 2018

Robitaille Y

3

1 reference

10 February 2018

Etienne P

4

1 reference

10 February 2018

Wood P

5

1 reference

10 February 2018

Nair NP

6

1 reference

10 February 2018

Gauthier S

7

1 reference

10 February 2018

publication date

1 November 1986

1 reference

10 February 2018

Canadian Journal of Neurological Sciences

published in

1 reference

10 February 2018

volume

13

1 reference

10 February 2018

page(s)

503-510

1 reference

10 February 2018

issue

4 Suppl

1 reference

10 February 2018

Evidence for the existence of serotonin type-2 receptors on cholinergic terminals in rat cortex

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Quantitative autoradiography of [3H]hemicholinium-3 binding sites in rat brain.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Neuropeptide Y-like immunoreactivity in neuritic plaques of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Evidence for a cholinergic projection to neocortex from neurons in basal forebrain

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Reduced lumbar CSF somatostatin in levels in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Nicotinic acetylcholine binding sites in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Neuropeptide Y distribution in human brain

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Translocation of protein kinase C activity may mediate hippocampal long-term potentiation.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

A post-mortem study of the cholinergic and GABA systems in senile dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Neuropeptides in aging and dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

https://api.crossref.org/works/10.1017%2FS0317167100037215

1 reference

7 January 2021

The nucleus basalis magnocellularis: The origin of a cholinergic projection to the neocortex of the rat

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Substance P immunoreactivity within neuritic plaques.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Senile dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Somatostatin-like immunoreactivity within neuritic plaques.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Reduced density of sodium-dependent [3H]hemicholinium-3 binding sites in the anterior cerebral cortex of rats following chemical destruction of the nucleus basalis magnocellularis.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Reduced calcium uptake by rat brain mitochondria and synaptosomes in response to aging.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Muscarinic receptor compensation in hippocampus of Alzheimer patients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and down's syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Localization and characterization of brain somatostatin receptors as studied with somatostatin-14 and somatostatin-28 receptor radioautography.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Neuropeptide Y (NPY) binding sites in rat brain labeled with 125I-Bolton-Hunter NPY: comparative potencies of various polypeptides on brain NPY binding and biological responses in the rat vas deferens.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Comparative localization of putative pre- and postsynaptic markers of muscarinic cholinergic nerve terminals in rat brain.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Acetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Choline analogues: their use in studies of acetylcholine synthesis, storage, and release

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

The 12th J. A. F. Stevenson Memorial Lecture: Aging, Alzheimer's disease, and the cholinergic system

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Evidence for cholinergic neurites in senile plaques.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Location of neuronal tangles in somatostatin neurones in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Glutamic acid decarboxylase-like immunoreactive neurites in senile plaques.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT).

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Changes in the brain catecholamines in patients with dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Changes of Biogenic Amines and Their Metabolites in Postmortem Brains from Patients with Alzheimer-Type Dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Monoamine metabolism in senile dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Transmitter deficits in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Serotonin receptor changes in dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Serotoninergic system in dementia of the Alzheimer type. Abnormal forms of 5-hydroxytryptophan and serotonin in cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's-type dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Presynaptic cholinergic dysfunction in patients with dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Autoradiographic distribution of muscarinic [3H]acetylcholine receptors in rat brain: comparison with antagonists.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Pre- and postsynaptic neurochemical alterations in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Distribution of Alzheimer's neurofibrillary changes in the brain stem and hypothalamus of senile dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Autoradiographic localization of muscarinic cholinergic receptors in the hippocampus of patients with senile dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Identification of sodium-dependent, high-affinity choline uptake sites in rat brain with [3H]hemicholinium-3.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Somatostatin and (D-Trp8, D-Cys14)-somatostatin delay extinction and reverse electroconvulsive shock induced amnesia in rats.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Sodium-dependent high-affinity binding of [3H]hemicholinium-3 in the rat brain: a potentially selective marker for presynaptic cholinergic sites.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Quantitative light microscopic autoradiography of [3H]hemicholinium-3 binding sites in the rat central nervous system: a novel biochemical marker for mapping the distribution of cholinergic nerve terminals.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Characterization of [3H]hemicholinium-3 binding associated with neuronal choline uptake sites in rat brain membranes.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Demonstration of a receptor in Torpedo synaptic vesicles for the acetylcholine storage blocker L-trans-2-(4-phenyl[3,4-3H]-piperidino) cyclohexanol

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Neuropeptide Y and peptide YY neuronal and endocrine systems

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Neuropeptide Y receptor in the rat brain.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Evidence for specific neuropeptide Y-binding sites in rat brain synaptosomes.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Neuropeptide Y receptors in rat brain: autoradiographic localization.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

Preliminary Report: Intracranial Cholinergic Drug Infusion in Patients with Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037215

7 January 2021

10.1017/S0317167100037215

Identifiers

DOI

0 references

PubMed ID

2878714

1 reference

10 February 2018